Predictive factors for mandibular... (2021 study) Skip to main content
Review Cancer Radiother 2021

Predictive factors for mandibular osteoradionecrosis after irradiation of head and neck cancers

Dutheil F, Guillemin F, Biau J, Pham-Dang N, Saroul N, Clavère P, et al., Cancer Radiother, 2021

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors reviewed the research on risk factors for mandibular osteoradionecrosis (ORN), a severe bone complication of radiation, in people treated for head and neck cancer.

What They Found

This review of risk factors for mandibular osteoradionecrosis after head and neck cancer radiation found that patient, disease, treatment and radiation dose factors were each linked to higher risk, with a mean mandibular dose above 48-54Gy and high percentages of mandibular volume receiving 40 to 60Gy appearing to separate higher-risk cases. Patient-related factors included intrinsic radiosensitivity, malnutrition with weight loss, active smoking, microcapillary involvement, poor oral status and low saliva. Disease-related factors included oral cavity tumours, large tumour size and tumour invasion of the mandible. Treatment-related factors included surgery on the primary tumour, concurrent radio-chemotherapy, tooth removal after irradiation, no stomatological follow-up or daily fluoride gutters, and not following curative healing treatments.

What This Means for Canadian Patients

The abstract does not address hyperbaric oxygen therapy. It covers how to identify who is at higher risk of ORN before and after head and neck cancer care. People who have had head and neck radiation can ask their cancer team about their own risk, including dental follow-up and the radiation dose to the jaw.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract describes risk factors and dose thresholds as associations that "appear" to matter, gives no study counts or sample sizes, and does not show that any single factor causes ORN.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Radiation Injury
Source Pubmed
PubMed ID 33836955
Year Published 2021
Journal Cancer Radiother
MeSH Terms Bone Density Conservation Agents; Clodronic Acid; Drug Therapy, Combination; Head and Neck Neoplasms; Humans; Hyperbaric Oxygenation; Mandibular Diseases; Osteoradionecrosis; Pentoxifylline; Radiotherapy Dosage; Risk Factors; Tocopherols

Cite This Study

Share

This study relates to Delayed Radiation Injury. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Radiation Injury

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 17, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology